Who are Codify Therapeutics's investors?

Codify Therapeutics's investors include SR One Capital Management.

Codify Therapeutics

1 known investors

Find your way into Codify Therapeutics

Codify Therapeutics is a discovery-stage biotech developing cancer therapeutics that target abnormal alternative RNA splicing, such as in splicing-factor-mutant leukemias.

Investors · 1

SR One Capital ManagementRedwood City

In the news

Targeting EZH2 Oncogenic Splicing: Decoding the Regulatory Network and Antisense Correction | bioRxivbiorxiv.org · Jan 2026

A Multi-Site Break through Cancer Trial: Phase II Study Investigating Dual Inhibition of BCL2 and Menin in AML MRD Using the Combination of Venetoclax and Revumenib (Trial In Progress) | Blood | American Society of Hematologyashpublications.org · Nov 2024

Frequently asked questions

What does Codify Therapeutics do?: Codify Therapeutics is a discovery-stage biotech developing cancer therapeutics that target abnormal alternative RNA splicing, such as in splicing-factor-mutant leukemias.
Who are Codify Therapeutics's investors?: Codify Therapeutics's investors include SR One Capital Management.